Danegaptide hydrochloride

N/A

Report date: 2025/06/25 17:24:25
NME

Base Information

Drug NameDanegaptide hydrochloride
Drug Alias Name盐酸达奈加肽DanegaptidumDanegaptida达奈加肽盐酸盐danegaptide +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGap junction proteins modulatorsImmunostimulants
TargetsGap junction proteins
Therapy Area/IndicationsDiabetic macular oedemaMyocardial InfarctionArrhythmias, Cardiac +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmarkGermany +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesBreye Therapeutics ApS
Inactive CompaniesWyeth LlcZealand Pharma A/S
Active IndicationsDiabetic macular oedemaMacular Edema
Inactive IndicationsMyocardial InfarctionArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksKEGG